Revenue

With dual robotic arms and AI radar, Dreame's award-winning X-Wind AC offers personalized airflow, signaling a new era for intelligent home technology.

A massive 20-year pact between Meta and Vistra will revive three nuclear plants, adding new carbon-free power to fuel the AI and data center revolution.

Kezar Life Sciences faces a critical FDA meeting for its novel liver disease drug, a decision that could bring hope to patients and define the company's future.

Laser tool maker Huepar validates its 5-year warranty with automated precision and plans a major service expansion in the UK, Europe, and the US.

At CES 2026, Chinese startup KunlunMeta and AMD launched a portable AI terminal, promising unprecedented mobile productivity and data privacy.

Pandora's 2025 growth slows amid weak consumer sentiment, but a new CEO plans a strategic reset to combat rising costs and boost brand desirability.

Amid a major corporate restructure, Atos partners with the World DanceSport Federation, betting on tech to transform the ballroom and secure its market lead.

Sanuwave Health posts record revenue, defying industry-wide turmoil as reimbursement cuts reshape the advanced wound care market. How did they do it?

Debuting at CES 2026, ANTHBOT's new robotic mowers do more than just cut grass—they sweep, collect, and mulch, challenging industry giants.

A 2.9 MEUR deal for GomSpace to design lunar spacecraft for a major North American firm signals a new era for small satellites in deep space exploration.

As 2026 begins, the crypto market sees a split personality: a wild memecoin surge alongside a steady, tech-driven recovery in the AI sector.

Global Capability Centers are shedding their cost-center image, embracing AI-first models and expanding into new Indian cities to become strategic innovators.

The semiconductor giant's stellar revenue, driven by a 19% surge in its core packaging business, confirms strong demand for AI and advanced tech.

A new AI-designed vaccine, TG4050, has prevented relapse in all head and neck cancer patients in a key trial, signaling a breakthrough in personalized medicine.

At CES 2026, an awards ceremony marks two decades of upheaval, chronicling China's rise from follower to leader in the global electronics industry.

Belgian biotech MRM Health gets the green light for a Phase 2b trial of MH002, a novel 'living drug' aimed at revolutionizing ulcerative colitis care.

Making its CES debut, Chinese supplier InfiMotion unveiled next-gen electric drives that promise more power and efficiency in a lighter, integrated package.

AS Tallinna Sadam reports robust 2025 results, with a major jump in liquid bulk cargo and a strong rebound in cruise tourism signaling regional recovery.

Swiss lab automation giant Tecan shows signs of a turnaround with robust H2 2025 orders, betting on AI to navigate a recovering life sciences market.

As Valneva meets investors, all eyes are on its pivotal Lyme disease vaccine data, a potential game-changer for public health and the company's future.